Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Lyka Labs Limited is a pharmaceutical products and services provider. The Company is primarily engaged in formulation and manufacturing lyophilized products.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
As per the SEBI Circular dated 31st December 2024 read with the NSE Circular dated 2nd January 2025, regarding the implementation of recommendations by the Expert Committee for facilitating ease of doing business for listed entities, kindly refer to the attached integrated Filing (Governance) for the quarter 31st December, 2024 | Download
As per the SEBI Circular dated 31st December 2024 read with the NSE Circular dated 2nd January 2025, regarding the implementation of recommendations by the Expert Committee for facilitating ease of doing business for listed entities, kindly refer to the attached integrated Filing (Governance) for the quarter 31st December, 2024 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant